UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $17

Bath & Body Works, Inc.

Bath & Body Works, Inc.

BBWI

0.00

UBS analyst Jay Sole maintains Bath & Body Works (NYSE: BBWI) with a Neutral and lowers the price target from $19 to $17.